Plozalizumab

1610761-46-0

CCR

Microbiology/Virology|||GPCR/G Protein|||Immunology/Inflammation

0.988

Plozalizumab (MLN-1202) is a humanized, selective, and potent anti-CCR2 antibody with antitumor activity, used in the study of malignant melanoma.

Cool pack

-20°C

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS1208611-01 0.02 mg (E-Coli)

Ask

MBS1208611-02 0.1 mg (E-Coli)

Ask

MBS1208611-03 0.02 mg (Yeast)

Ask

MBS1208611-04 0.1 mg (Yeast)

Ask

MBS1208611-05 0.02 mg (Baculovirus)

Ask

MBS1208611-06 0.02 mg (Mammalian-Cell)

Ask